Peer Review History
| Original SubmissionApril 14, 2025 |
|---|
|
Dear Dr. Chang, Please submit your revised manuscript by Jul 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Manuela Mendonça Figueirêdo Coelho, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following financial disclosure: [This research was funded through an industry-academia collaboration agreement between Shuang Ho Hospital, Taipei Medical University and Bamboo Technology Co., Ltd. in Taiwan, with the project code A-112-006-S.]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: [This research was funded through an industry-academia collaboration agreement between Shuang Ho Hospital, Taipei Medical University and Bamboo Technology Co., Ltd. in Taiwan, with the project code A-112-006-S.] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [This research was funded through an industry-academia collaboration agreement between Shuang Ho Hospital, Taipei Medical University and Bamboo Technology Co., Ltd. in Taiwan, with the project code A-112-006-S.]. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. In the online submission form, you indicated that [The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 6. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Reviewer Comments 1. Ethical Considerations: The manuscript mentions IRB approval and informed consent but lacks details on data anonymization and voice data protection. Given the sensitivity of biometric data, clarify how voice recordings were stored, processed, and anonymized to ensure participant confidentiality. 2. Sample Representation: While the sample is predominantly female (85.4%), analyses involving menstrual cycles apply only to female participants. The manuscript should explicitly state whether male nurses were excluded from these specific analyses and discuss the implications for generalizability. 3. Measurement Validity: The AI VER app’s accuracy (70%) is moderate. Discuss limitations arising from this accuracy level (e.g., potential misclassification bias) and its impact on results. Justify the choice of a decision tree classifier over more advanced models (e.g., neural networks) for emotion classification, addressing trade-offs between interpretability and performance. 4. Causality vs. Correlation: The discussion occasionally implies causation (e.g., fear leading to peptic ulcers). Clarify that the study identifies associations, not causality, and avoid overinterpretation of mechanisms without longitudinal or experimental evidence. 5. Confounding Variables: Key confounders like workload intensity, job-specific stressors, or comorbid mental health conditions (e.g., anxiety) are not controlled. Acknowledge this limitation and suggest future studies to account for these variables. 6. Test-Rest Reliability: The retest sample size (n=30) is small. While a 15% loss rate is mentioned, consider expanding the retest cohort to enhance reliability estimates, particularly for fear (moderate ICC). 7. Cultural Context: The study was conducted in Taiwan. Discuss potential cultural influences on emotion expression (e.g., social desirability bias) and how these might affect the app’s performance or generalizability to other populations. 8. Data Availability: PLOS ONE mandates public data availability unless restricted by ethical/legal concerns. The current statement (“available upon request”) may not comply. Either deposit data in a repository with access controls or provide a detailed justification for restrictions. 9. Figures and Tables: Figure 1 is referenced but not included in the manuscript draft. Ensure all figures are properly formatted and captioned. Table 1’s title (“three patient groups”) is inaccurate (participants are nurses). Revise for clarity. 10. Language and Clarity: Several sentences are grammatically awkward or unclear (e.g., “The scores of the four emotions are A (anger), B (fear), C (happiness), and D (sadness)…”). Professional editing for language fluency is recommended. 11. Conflict of Interest: The VER model was developed by Bamboo Technology Co., Ltd., which funded the study. While the authors declare no competing interests, explicitly address potential biases (e.g., whether the company influenced data analysis/interpretation). 12. Methodological Rigor: The app’s training data (RAVDESS and “members”) lacks specificity. Describe the demographic composition of training datasets to assess model generalizability. For menstrual cycle assessment, clarify how “irregularity” was operationalized (self-report vs. clinical criteria) to ensure validity. Recommendation: The study addresses an important topic with practical implications for nurse well-being. However, revisions addressing the above points are essential to strengthen validity, clarity, and compliance with journal guidelines. With these improvements, the manuscript would make a valuable contribution to the field. Reviewer #2: The growing burden of mental health issues among healthcare professionals represents a global challenge. Health systems exert significant structural pressures on professionals, including nurses. While there is often a tendency to focus solely on individual determinants, it is essential to consider environmental and systemic factors, particularly workplace-related determinants, that influence mental health. Recognizing this broader context allows for a more comprehensive understanding: addressing mental health issues requires not only individual-level support but also systemic changes to the environments that contribute to psychological distress. This holistic approach is a major contemporary challenge for improving health outcomes and could be a little bit more addressed in the discussion part of your work. The study could benefit from numerous revisions to enhance methodological rigor and strengthen the discussion (while taking into account limitations) in order to effectively disseminate its findings. #Abstract: Objectives: “AI” should be fully written line 21 as it is the first time you introduce it. Results: Describe what kind of “exercise” you are talking about. Is it a physical exercise, a professional exercise? Conclusion: Line 36 the word “that” is useless. #Introduction: Line 54 you are referring to VER with a paper that you cite to highlight that the VER could be used in multiple fields such as screening for depression. When I read the paper you cited (4th reference), I could not find in the paper an application of VER except for Alzheimer’s disease. I feel like this article was more about artificial intelligence techniques that could diagnose numerous diseases but not with the speech detection in general. The way you used that reference could be misleading and you should correct that. Line 60, prefer the term “socio-demographic” rather than “personal”. Line 61 for your mention that “studies have found gradually increasing work pressure on nurses.”, please provide references accordingly. In line 66, since no evidence-based references support this statement, I would suggest using the term “could” instead of “can”. Line 68: Please rewrite the sentence. “developed based” is grammatically incorrect. The introduction section is generally well structured but may be somewhat too concise. It could benefit from additional contextual information to provide a more comprehensive background on the topic. #Methods: Line 79: “study subjects” � “study participants” Please indicate in this section how many researchers were recording the nurse’s voice. Please provide a translated questionnaire that nurses were answering. Line 86: You mention that nurses recorded their voice for 60 seconds. However, in Figure 1 we can observe a length of conversation that appears to last 1 minutes and 30 seconds. Is 60 seconds a minimum required? Please clarify this. Also, could you please be more precise on what the nurse is supposed to talk about. No information is given on the content / topic of what the nurse is saying. Line 91, 1st sentence: This should be included in the results section. Line 91: Please make clearer the sentence for which you cite citation number 12 in which there is no data specifically on “emotion measurement tools” in this paper. Develop this aspect. Ethical considerations section: please write it in past tense. Line 109 “Research instruments”: Please introduce this section properly. Line 111: What was the rationale for collecting data on religion? Is there any scientific literature related to the study topic that justifies its inclusion? It is important to ensure that all collected data comply with international ethical standards, particularly regarding confidentiality and relevance. Line 112: What do you mean by “living habits” or “work experience”? Please be more precise on the variables you collected. Indeed, it contrasts with the level of detail you provided for the scores in the research instruments section. Line 197: Please specify how much data you tested the model with and provide more precise data on its results. Line 207: You mention using t-tests. Detail the conditions under which this test was applied: was the normality of the variable distributions verified for this parametric test? #Results The results related to background characteristics should be compared in the discussion section with national statistics on nurses to support the external validity of your findings. Table 1 (line 232): Could you clarify the choice of this title? The reference to “three groups” is unclear, and the use of the term “patient” seems inconsistent with your study population, which consists solely of healthcare professionals (nurses). Please provide a justification for this wording. Tables: Please add in the note part (or title) the total number of participants included for these data. Keep a homogeneous formatting for this information across tables. Line 254: Consider adding “in this study population” or “among nurses” to avoid overgeneralization of the findings. Line 273: Please confirm the wording “negative automatic thoughts”. #Discussion This section needs major revision. While this section effectively presents the key results and relates them to existing literature, it lacks a critical analysis of the study. Notably, no limitations are discussed, despite several being apparent. For a more robust scientific discussion, a dedicated “Limitations” section should be added. You should consider addressing biases inherent to your study design, such as the small sample size, recall bias related to the use of self-administered questionnaires (especially for reporting physical symptoms or past medical history), and any other relevant methodological constraints. Clearly acknowledging these limitations will strengthen the transparency and credibility of your findings. You should clearly state some limitations with a discussion of internal and external validity. #General comments: If the AI VER app detects and reports a high sadness score, are there specific referral procedures in place to connect the nurse with a mental health professional? Additionally, your paper does not clearly explain how the various types of collected data were processed. Readers may be left with the impression that a significant amount of data was gathered without a clear account of how each type was analyzed or utilized. The clarity of your work would benefit from a more detailed explanation of your data collection methods and the subsequent data processing steps. This would enhance the transparency and reproducibility of your study. Thank you for your work on that interesting and important topic! ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Matthieu Lebrat ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Chang, plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Helen Howard Staff Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: The manuscript has been evaluated by two reviewers, and their comments are available below. The reviewers have raised a number of concerns that need attention. In particular, they request additional information on the AI tool, its validation, and the controlling for confounders. The reviewers also request that a copy of the questionnaire is provided as supplementary information. Could you please revise the manuscript to carefully address the concerns raised? [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The study addresses an important topic with potential practical value. However, the critical lack of detail regarding the AI app and its validation, coupled with limitations in study design and analysis, currently undermine the conclusions. Addressing these concerns, particularly providing full transparency about the AI tool and its validation, and controlling for confounders, is essential for the manuscript to make a significant scientific contribution. The ethical handling of sensitive voice data must also be clearly demonstrated. Reviewer #2: Thank you for your revision that significantly enhanced the manuscript quality. I recommend to accept the paper after my last comment: Regarding point 10 that I raised (Reviewer 2). I do not see any questionnaire that the nurses filled out even though you answered that you will provide it. Is this an error ? It should be in Supplementary file. King regards. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: MATTHIEU LEBRAT ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Chang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mikiyas Amare Getu Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: The topic is innovative and highly relevant to the emerging field of digital emotion recognition in healthcare. However, there are several areas of weakness that may need revision before final acceptance: 1) The title is overly long; consider shortening to emphasize the primary focus 2) Abstract lacks detail on the psychometric methods (e.g., type of reliability coefficients, what “moderate and positive correlation” means numerically). 3) The AI system’s accuracy (≈70–80%) should be contextualized — was this sufficient for clinical applications? 4) Which validity do you mean? Criterion validity, convergent validity, or concurrent validity? 5) Regarding sample size: Convenience sampling in one hospital limits generalizability; this needs to be discussed as a limitation 6) No factor analysis was performed to assess construct validity. And no inter-rater or internal consistency analysis for the app (e.g., Cronbach’s α or split-half reliability). Justify it 7) Effect sizes are small (e.g., β = .11 or .13) and their practical significance is not discussed. 8) Discussion tends to overstate the implications — the conclusion that the app can “objectively detect emotional patterns” may be premature given moderate correlations and app accuracy. 9) Causal language should be avoided (e.g., “Peptic ulcers were associated with fear” → should be “Peptic ulcers correlated with fear”). 10) How does the app perform compared with self-reported emotion scales (e.g., accuracy, AUC)? 11) The limitation should include Single-institution sample bias: Self-report physical health data (potential recall bias). 12) Was there any independent validation to prevent bias from the company developing the app? [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: The authors have addressed prior review comments satisfactorily, and the study adheres to ethical standards. No further concerns regarding dual publication or ethics. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
<p>Reliability, validity, and correlates of an AI voice emotion recognition app among nurses PONE-D-25-20092R3 Dear Dr. Wen-Pei Chang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mikiyas Amare Getu Academic Editor PLOS One |
| Formally Accepted |
|
PONE-D-25-20092R3 PLOS One Dear Dr. Chang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mikiyas Amare Getu Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .